Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

When the bullet hits the target

Vittorio Rosti1

  • 1Laboratory of Organ Transplantation, IRCCS Policlinico San Matteo, Pavia, Italy. virosti@tin.it

Haematologica
|June 13, 2003
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding the link between PMN-MDSCs and CXCL8-CXCR1/2 axis in primary myelofibrosis.

Frontiers in cell and developmental biology·2026
Same author

Response to Comment on: "Clonal megakaryocyte dysplasia with normal blood values: a covert, thrombosis-prone, early myeloproliferative neoplasm."

Haematologica·2026
Same author

Are Myeloproliferative Neoplasms-Unclassifiable Really Unclassifiable?

EJHaem·2026
Same author

Prognostic value of anemia plus thrombocytopenia in primary myelofibrosis.

Leukemia·2026
Same author

The influence of patient engagement and self-efficacy on self-care in myeloproliferative neoplasms: A mediation analysis.

European journal of oncology nursing : the official journal of European Oncology Nursing Society·2025
Same author

Clonal megakaryocyte dysplasia with normal blood values: a covert, thrombosis-prone, early myeloproliferative neoplasm.

Haematologica·2025
Same journal

<i>Erratum</i> to: "Isatuximab plus bortezomib, lenalidomide, and dexamethasone for transplant-ineligible newly diagnosed multiple myeloma patients: a frailty subgroup analysis of the IMROZ trial".

Haematologica·2026
Same journal

Introduction to the Review Series. Chronic myeloid leukemia in 2026.

Haematologica·2026
Same journal

Metformin: interferon's new dancing partner?

Haematologica·2026
Same journal

A potent and manipulable graft-<i>versus</i>-leukemia effect underpins the increasingly important role of transplantation in acute myeloid leukemia.

Haematologica·2026
Same journal

Gradient of CD79B expression in diffuse large B-cell lymphoma corresponds to stages of germinal center B-cell differentiation.

Haematologica·2026
Same journal

Academic point-of-care anti-CD19 CAR T-cell therapy induces durable remission and transient paroxysmal nocturnal hemoglobinuria-type cell expansion in a patient with multi-refractory immune thrombocytopenia.

Haematologica·2026
See all related articles